An artificial pancreas, continuous control blood sugar levels help provide timely insulin more effective than traditional methods of insulin in controlling diabetes type 1. It was discovered by scientists Academy of Clinical Research Montreal (IRCM), Canada.
IRCM study published in the Journal of the Canadian Medical Association said 28/1 day trial was conducted for patients with type 1 diabetes showed the artificial pancreas has two hormones has improved 15% level blood sugar levels and lower risk of hypoglycemia to 8 times higher than the methods currently insulin supplementation.
Artificial pancreas system is built on the basis of intelligent algorithms often change control blood glucose levels of patients to calculate the amount of insulin needed.
According to the method of supplementing traditional insulin, diabetics often have to check your blood sugar to control the amount of insulin into the body.
According to the researchers, the fact about 2/3 of the patients did not perform this work.
Artificial pancreas could meet this demand while lowering the risk of decreased insulin in the blood, the most dangerous state for diabetics and the adverse effects the most common in insulin therapy.
Besides, artificial pancreas may distribute glucogon, nature helps increase blood sugar levels when they are too low.
Type 1 diabetes is a disease that occurs when the body does not produce enough insulin, leading to high blood sugar levels dangerous.
Glycemic control by insulin is the key to preventing complications related to high blood sugar, such as blindness or kidney failure.
The treatment also contributes to reduced insulin to prevent blood - a condition in which the blood sugar is too low can cause patient confusion, disorientation or even loss of awareness.
The IRCM researchers said it would conduct a clinical trial to test the effect of the artificial pancreas system for longer periods and in all age groups.
This finding is considered to have the potential to significantly improve diabetes control and ensure the safety of patients during treatment.
IRCM study published in the Journal of the Canadian Medical Association said 28/1 day trial was conducted for patients with type 1 diabetes showed the artificial pancreas has two hormones has improved 15% level blood sugar levels and lower risk of hypoglycemia to 8 times higher than the methods currently insulin supplementation.
Artificial pancreas system is built on the basis of intelligent algorithms often change control blood glucose levels of patients to calculate the amount of insulin needed.
According to the method of supplementing traditional insulin, diabetics often have to check your blood sugar to control the amount of insulin into the body.
According to the researchers, the fact about 2/3 of the patients did not perform this work.
Artificial pancreas could meet this demand while lowering the risk of decreased insulin in the blood, the most dangerous state for diabetics and the adverse effects the most common in insulin therapy.
Besides, artificial pancreas may distribute glucogon, nature helps increase blood sugar levels when they are too low.
Type 1 diabetes is a disease that occurs when the body does not produce enough insulin, leading to high blood sugar levels dangerous.
Glycemic control by insulin is the key to preventing complications related to high blood sugar, such as blindness or kidney failure.
The treatment also contributes to reduced insulin to prevent blood - a condition in which the blood sugar is too low can cause patient confusion, disorientation or even loss of awareness.
The IRCM researchers said it would conduct a clinical trial to test the effect of the artificial pancreas system for longer periods and in all age groups.
This finding is considered to have the potential to significantly improve diabetes control and ensure the safety of patients during treatment.
0 comments:
Đăng nhận xét